Toll-like receptor 2 signalling as a potential therapeutic target in gastric cancer

胃癌是世界上第四大致命癌症。胃癌与炎症密切相关，我们已经证明一种关键的炎症分子，称为toll样受体2 (TLR2)，可以推动胃癌的发展。然而，这是以非炎症的方式发生的。我的研究旨在了解TLR2如何参与胃癌的进展，最终目标是找到疾病的早期生物标志物，并开发更好的治疗方法。

Stomach cancer is the fourth most deadly cancer in the world. Stomach cancer is closely linked with inflammation, and we have shown that a key inflammatory molecule, called toll-like receptor 2 (TLR2), can drive the development of stomach cancer. However, this occurs in a non-inflammatory manner. My research aims to understand how TLR2 is involved in the progression of stomach cancer, with the ultimate goal to find an early biomarker of disease, and to develop better therapies.